Outbreak of measles - Symptoms, Causes, Treatment & Prevention

```html

Overview

Measles (also called rubeola) is a highly contagious viral infection caused by the Measles morbillivirus. It spreads through respiratory droplets when an infected person coughs or sneezes, and the virus can remain viable in the air or on surfaces for up to two hours.

Although measles can affect anyone, it most frequently occurs in children under five years of age who are not fully immunized. In high‑income countries with >95% vaccination coverage, endemic transmission has been eliminated, but outbreaks still happen when imported cases encounter pockets of under‑immunized individuals.

Global burden (2022): The World Health Organization (WHO) estimated 120 million measles cases worldwide, resulting in ≈ 200 000 deaths, primarily in children <5 years old. In the United States, the CDC reported 1 238 cases in 2023 – the highest number in the last decade, underscoring that outbreaks can re‑emerge quickly when immunity gaps develop.

Symptoms

Symptoms typically appear 10‑14 days after exposure (the incubation period). The classic presentation follows three stages:

• Prodromal phase (2‑4 days) – high fever (often >40 °C/104 °F), cough, coryza (runny nose), and conjunctivitis (“the three C’s”).
• Koplik spots – small white‑blue lesions on the buccal mucosa that appear 2‑3 days after the prodrome and are pathognomonic for measles.
• Rash phase (3‑5 days) – a maculopapular rash that begins at the hairline, spreads downwards to the face, trunk, and limbs. The rash typically lasts 5‑6 days and may become confluent.

Additional symptoms that can occur:

• Fatigue and weakness
• Muscle aches (myalgia)
• Diarrhea (more common in children)
• Ear infections (otitis media)
• Upper respiratory tract infection symptoms that can mimic a common cold

Causes and Risk Factors

Cause: Measles is caused by the measles virus, a single‑stranded, enveloped RNA virus in the Paramyxoviridae family. The virus infects epithelial cells of the respiratory tract and then spreads systemically.

Key risk factors for infection during an outbreak

• Unvaccinated or partially vaccinated status – one dose of the measles‑containing vaccine (MCV) provides ~93% protection; two doses raise it to >97%.
• Age – infants too young to be vaccinated (<6 months) and children 1‑4 years old have the highest attack rates.
• Travel to endemic regions – exposure during international travel can import the virus.
• Living in crowded settings – schools, daycare centers, refugee camps, and prisons facilitate person‑to‑person spread.
• Immunocompromised conditions – HIV infection, cancer chemotherapy, solid organ transplantation, or use of high‑dose steroids.
• Pregnancy – pregnant women who are not immune are at higher risk for severe disease and complications.

Diagnosis

Diagnosis is clinical but should be confirmed with laboratory testing, especially during an outbreak.

Clinical criteria

1. High fever with cough, coryza, conjunctivitis.
2. Koplik spots on the buccal mucosa.
3. Maculopapular rash that spreads from head to toe.

Laboratory tests

• Reverse transcription polymerase chain reaction (RT‑PCR) – detects measles RNA from throat swabs, nasopharyngeal aspirates, or urine. It is the preferred test because results are rapid (24‑48 h) and highly sensitive.
• Serology – measles‑specific IgM antibodies appear 3‑5 days after rash onset. Paired acute‑ and convalescent‑phase IgG titers can confirm recent infection.
• Viral culture – rarely performed today due to the need for biosafety level‑2/3 labs.

Treatment Options

There is no specific antiviral medication approved for routine measles care. Management focuses on supportive treatment and preventing complications.

Supportive care

• Fever control – acetaminophen (paracetamol) or ibuprofen as per age‑appropriate dosing.
• Hydration – encourage oral fluids; intravenous fluids may be needed if vomiting or dehydration occurs.
• Rest and isolation – patients are contagious from four days before to four days after rash onset; stay home until 24 h after rash disappears.

Specific interventions for high‑risk patients

• Vitamin A supplementation – per WHO guidelines, two doses (24 h apart) of 200,000 IU for adults or weight‑based dosing for children reduce morbidity and mortality, especially in malnourished children.
• Antibiotics – not for the virus itself, but for secondary bacterial infections such as pneumonia or otitis media.
• Immunoglobulin (IG) prophylaxis – for unvaccinated infants (<6 months) or immunocompromised individuals exposed to measles, 0.5 mL/kg of IG within six days of exposure can modify disease severity.

Experimental antivirals

Ribavirin has been used in severe cases (e.g., immunocompromised hosts) on a case‑by‑case basis, but robust evidence is lacking. It should only be administered in a hospital setting under infectious‑disease specialist guidance.

Living with an Outbreak of Measles

While most people recover fully, the social and practical implications of an outbreak can be stressful. Below are actionable tips for patients, caregivers, and community members.

Daily management

• Isolation – stay in a single, well‑ventilated room away from vulnerable individuals (infants <6 months, pregnant women, immunocompromised). Use a separate bathroom if possible.
• Hydration & nutrition – aim for 1.5–2 L of fluids per day; soups, oral rehydration solutions, and soft foods are easier to tolerate if the throat is sore.
• Fever monitoring – check temperature 3–4 times daily. Seek care if fever persists >5 days or exceeds 40 °C (104 °F).
• Eye care – lubricating eye drops can relieve conjunctivitis; avoid rubbing eyes to reduce spread.
• Hygiene – wash hands frequently with soap for at least 20 seconds; use disposable tissues for coughs/sneezes.
• School/work policy – notify administrators of the diagnosis; most jurisdictions require a doctor’s note stating the individual is non‑contagious before returning.

Supporting children

• Provide plenty of fluids – diluted juice or oral rehydration salts.
• Offer bland foods (e.g., bananas, rice, applesauce) if appetite is low.
• Use age‑appropriate pain relievers for fever and discomfort.
• Keep an eye on ear pain – prompt antibiotic treatment can prevent mastoiditis.

Community actions

• Report suspected cases to local public‑health departments.
• Encourage neighbors to verify vaccination status; many health departments offer free MMR vaccination clinics during outbreaks.
• Participate in community‑wide “catch‑up” vaccination drives.

Prevention

Vaccination is the most effective tool. The measles‑containing vaccine (MMR – measles, mumps, rubella) is a live attenuated vaccine given in two doses.

Vaccination schedule

• First dose: 12‑15 months of age.
• Second dose: 4‑6 years of age (or earlier if traveling).
• Adults without documented immunity should receive at least one dose; two doses are recommended for healthcare workers, college students, and international travelers.

Other preventive measures

• Post‑exposure prophylaxis (PEP) – MMR vaccine given within 72 hours of exposure can prevent or modify disease in unimmunized individuals; IG is used for infants <6 months or immunocompromised patients.
• Hand hygiene & respiratory etiquette – reduces spread of all respiratory viruses.
• Isolation of cases – public‑health officials enforce exclusion from school/work until 24 h after rash resolution.
• Travel precautions – verify that you are up‑to‑date on MMR before visiting endemic areas; carry vaccination records.

Complications

While most people recover without lasting problems, measles can cause serious, sometimes fatal, complications, especially in children under five, adults over 20, and immunocompromised patients.

• Pneumonia – the most common cause of measles‑related death.
• Encephalitis – occurs in 1 per 1 000 cases; can lead to permanent neurologic deficits.
• Subacute sclerosing panencephalitis (SSPE) – a rare, fatal neurodegenerative disorder that appears years after infection.
• Acute otitis media – can cause temporary hearing loss.
• Diarrhea – may lead to dehydration, particularly in young children.
• Thrombocytopenia – low platelet count causing bruising or bleeding.
• Pregnancy complications – increased risk of miscarriage, preterm labor, and low birth weight.

When to Seek Emergency Care

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), National Institutes of Health (NIH), Cleveland Clinic, The Lancet Infectious Diseases (2023).

```